Three years after regenerative agriculture became one of agrifood’s favorite buzzwords, investors still can’t tell which corporate commitments are real. That’s the blunt conclusion of investor network FAIRR’s latest report, “Regenerative Agriculture: Moving from Ambition to Credibility,” which tracked 78 publicly listed agrifood companies between 2023 and 2026.
The report assesses whether these companies’ programs are becoming “more credible,” based on outcome strategies, measurable goals, MRV (monitoring, reporting, and verification), and support for farmers.
Share of companies referencing regenerative agriculture has barely moved, from 63% in 2023 to 64% in 2026.
Share of companies with quantified targets actually fell during the same time period, from 37% to 28%. FAIRR suggests two possible explanations: Either companies realized that their earlier targets were unrealistic given poor supply-chain traceability, or companies deliberately avoided numbers that create legal and reputational exposure if missed.
Either way, “the lack of specific commitments ultimately weakens the credibility of corporate claims about what will be implemented,” the report states.
“Ambition alone is insufficient. If regenerative agriculture is to support such outcomes, its credibility, delivery, and limits must be discussed transparently by companies and investors.”
Promises versus achievements
In many cases, corporate regen ag ambition outweighs substance when it comes to what they are actually achieving. For example, companies overwhelmingly set targets around deployment (e.g., number of acres regenerated, volume sourced) rather than outcomes (e.g., emissions cut, pesticide reductions).
Zero companies in the sample have a target to reduce pesticide use, despite 52% citing it as a goal. This is problematic, as two of the most common practices associated with regenerative agriculture—cover cropping and no-till farming—very often rely on synthetic chemical inputs.
“This type of contradiction can negatively affect the credibility of corporate regenerative agriculture initiatives,” FAIRR notes, adding that “the benefits of practices such as using cover crops, no tillage, and organic fertiliser can be significantly undermined if the risks associated with pesticide use or antimicrobial resistance are not assessed and mitigated.”
Farmer economics is another area where ambition talks louder than outcomes. Forty percent of companies now offer some financial support to farmers transitioning to regenerative practices (up from essentially undisclosed levels previously), but that support represents just 0.01% to 0.05% of revenue.
Nestlé’s disclosed investment, the highest in the sample, is roughly 0.25% of revenue. Only three companies—ADM, Kerry Group, and Kraft Heinz—publicly disclose per-acre or per-unit payment terms.
Corporate regen ag measurement improving
On the upside, measurement infrastructure is improving quickly. The share of companies measuring regenerative outcomes has more than tripled, from 16% in 2023 to 54% in 2026.
For investors in protein and packaged food companies specifically, the pork and poultry gap deserves scrutiny. Seventy percent of companies apply regenerative frameworks to crops versus just 10% for pork and poultry, a blind spot FAIRR calls “a critical coverage gap in corporate climate transition planning,” given how exposed these specific animal supply chains are to price volatility.
The report’s core message to institutional investors: regenerative agriculture claims deserve the same scrutiny as any other transition-plan disclosure.
Useful diligence questions for investors include whether a company has tied outcomes to its own materiality assessment, whether targets are outcome-based or just deployment-based, and whether farmer financial support scales meaningfully relative to revenue. As FAIRR puts it, regenerative agriculture “cannot be relied upon in isolation,” and neither can the disclosures describing it, without harder numbers behind them.
